Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03204786Phase 2/3Completed
Intranasal Vasopressin Treatment in Children With Autism
ASDAutismAutism Spectrum Disorder
PrincipalinvestigatorStart date: 2018-02-20
NCT01988623Not ApplicableCompleted
Pivotal Response Treatment for Individuals With Intellectual Disabilities
Intellectual DisabilitiesLanguage DisorderSpeech Delay
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Karen J. Parker, Ph.D.

Stanford University

Moderately Similar
1 trials

Shared therapeutic areas:

ASDAutistic DisorderAutism Spectrum Disorder

Worked with same sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Stanford University
Collaborated on 1 trial
Similarity Score34%

Antonio Hardan, MD

Stanford University

Related
12 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum DisorderASD

Worked with same sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Stanford University
Similarity Score15%

Gagan Joshi, MD

Massachusetts General Hospital

Related
12 trials

Shared therapeutic areas:

Autism Spectrum DisorderASDAutistic Disorder
Similarity Score15%

Janet Wozniak, MD

Massachusetts General Hospital

Related
11 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum Disorder
Similarity Score10%

Flavia Marino

Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)

Related
12 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum Disorder
Similarity Score10%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum Disorder
Similarity Score10%

James McCracken, MD

University of California, Los Angeles

Related
8 trials

Shared therapeutic areas:

Autism Spectrum DisorderAutistic Disorder

Worked with same sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Similarity Score10%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum Disorder
Similarity Score10%

Forbes D Porter, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
15 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum Disorder

Worked with same sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Similarity Score10%

Barbara B Biesecker

National Human Genome Research Institute (NHGRI)

Related
23 trials

Shared therapeutic areas:

Autistic DisorderAutism Spectrum Disorder
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03204786Phase 2/3PrincipalInvestigator

Intranasal Vasopressin Treatment in Children With Autism

ASDAutismAutism Spectrum Disorder
Completed
NCT01988623Not ApplicablePrincipalInvestigator

Pivotal Response Treatment for Individuals With Intellectual Disabilities

Intellectual DisabilitiesLanguage DisorderSpeech Delay
Completed

All 2 trials loaded